NO983850L - Farmas°ytisk blanding for immunomodulering basert pÕ peptider og adjuvanser - Google Patents
Farmas°ytisk blanding for immunomodulering basert pÕ peptider og adjuvanserInfo
- Publication number
- NO983850L NO983850L NO983850A NO983850A NO983850L NO 983850 L NO983850 L NO 983850L NO 983850 A NO983850 A NO 983850A NO 983850 A NO983850 A NO 983850A NO 983850 L NO983850 L NO 983850L
- Authority
- NO
- Norway
- Prior art keywords
- adjuvants
- peptides
- surface preparation
- pharmaceutical surface
- immunomodulation based
- Prior art date
Links
- 239000002671 adjuvant Substances 0.000 title 1
- 230000002519 immonomodulatory effect Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5156—Animal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19607044A DE19607044A1 (de) | 1996-02-24 | 1996-02-24 | Tumorvakzine und Verfahren zu ihrer Herstellung |
DE19638313A DE19638313C2 (de) | 1996-09-19 | 1996-09-19 | Pharmazeutische Zusammensetzung für die Immunmodulation |
DE19648687A DE19648687A1 (de) | 1996-11-25 | 1996-11-25 | Pharmazeutische Zusammensetzung für die Immunmodulation |
PCT/EP1997/000828 WO1997030721A1 (de) | 1996-02-24 | 1997-02-21 | Pharmazeutische zusammensetzung für die immunmodulation beruhend auf peptiden und adjuvantien |
Publications (2)
Publication Number | Publication Date |
---|---|
NO983850D0 NO983850D0 (no) | 1998-08-21 |
NO983850L true NO983850L (no) | 1998-10-21 |
Family
ID=27215945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO983850A NO983850L (no) | 1996-02-24 | 1998-08-21 | Farmas°ytisk blanding for immunomodulering basert pÕ peptider og adjuvanser |
Country Status (35)
Country | Link |
---|---|
US (1) | US7105162B1 (no) |
EP (1) | EP0881906B2 (no) |
JP (1) | JP4184433B2 (no) |
KR (1) | KR100457647B1 (no) |
CN (1) | CN1177610C (no) |
AR (1) | AR005945A1 (no) |
AT (1) | ATE274350T1 (no) |
AU (1) | AU722264B2 (no) |
BG (1) | BG63682B1 (no) |
BR (1) | BR9707694A (no) |
CA (1) | CA2243559C (no) |
CO (1) | CO4600681A1 (no) |
CZ (1) | CZ295396B6 (no) |
DE (1) | DE59711873D1 (no) |
DK (1) | DK0881906T4 (no) |
EE (1) | EE04481B1 (no) |
ES (1) | ES2225951T5 (no) |
HK (1) | HK1017257A1 (no) |
HR (1) | HRP970100B1 (no) |
HU (1) | HU224410B1 (no) |
ID (1) | ID16038A (no) |
IL (1) | IL125361A (no) |
MY (1) | MY119276A (no) |
NO (1) | NO983850L (no) |
NZ (1) | NZ332020A (no) |
PE (1) | PE55398A1 (no) |
PL (1) | PL189413B1 (no) |
PT (1) | PT881906E (no) |
RO (1) | RO119344B1 (no) |
RS (1) | RS50101B (no) |
SI (1) | SI0881906T2 (no) |
SK (1) | SK284582B6 (no) |
TR (1) | TR199801649T2 (no) |
TW (1) | TW585774B (no) |
WO (1) | WO1997030721A1 (no) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO4600681A1 (es) | 1996-02-24 | 1998-05-08 | Boehringer Ingelheim Pharma | Composicion farmaceutica para la modulacion inmunitaria |
DE19803453A1 (de) * | 1998-01-30 | 1999-08-12 | Boehringer Ingelheim Int | Vakzine |
EP1061951B1 (en) * | 1998-02-25 | 2003-08-27 | THE GOVERNMENT OF THE UNITED STATES, as represented by THE SECRETARY OF THE ARMY | Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin |
WO1999053912A1 (en) * | 1998-04-20 | 1999-10-28 | Torrey Pines Institute For Molecular Studies | Topical immunostimulation to induce langerhans cell migration |
US7776343B1 (en) * | 1999-02-17 | 2010-08-17 | Csl Limited | Immunogenic complexes and methods relating thereto |
DE19909503A1 (de) * | 1999-03-04 | 2000-09-07 | Boehringer Ingelheim Int | Tumorassoziiertes Antigen |
US6809179B1 (en) | 1999-08-04 | 2004-10-26 | Boehringer Ingelheim International Gmbh | Tumor-associated antigen (R11) |
AT408721B (de) | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
US20070031446A1 (en) | 2003-07-11 | 2007-02-08 | Intercell Ag | Hcv vaccines |
AT409085B (de) * | 2000-01-28 | 2002-05-27 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen |
US20020009491A1 (en) * | 2000-02-14 | 2002-01-24 | Rothbard Jonathan B. | Compositions and methods for enhancing drug delivery across biological membranes and tissues |
AT409762B (de) * | 2000-04-13 | 2002-11-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung von zytokin sekretierenden zellen |
AT410173B (de) | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
KR20020014459A (ko) * | 2000-08-18 | 2002-02-25 | 서진호 | 양이온성 아미노산이 부가된 융합단백질 및 이를 이용한생물공정의 개선방법 |
WO2002053185A2 (en) * | 2001-01-05 | 2002-07-11 | Intercell Ag | Anti-inflammatory use of polycationic compounds |
US7244438B2 (en) | 2001-01-05 | 2007-07-17 | Intercell Ag | Uses for polycationic compounds |
EP1347775B1 (en) * | 2001-01-05 | 2016-11-30 | Valneva Austria GmbH | Uses for polycationic compounds as vaccine adjuvants |
AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
FR2824326B1 (fr) * | 2001-05-04 | 2004-03-19 | Commissariat Energie Atomique | Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications |
AU2002358616A1 (en) * | 2001-12-07 | 2003-06-17 | Intercell Ag | Immunostimulatory oligodeoxynucleotides |
US20050221350A1 (en) * | 2002-05-29 | 2005-10-06 | Toni Weinschenk | Method for identifying immunoreactive peptides |
CA2484941A1 (en) | 2002-07-24 | 2004-02-05 | Intercell Ag | Antigens encoded by alternative reading frame from pathogenic viruses |
US7378234B2 (en) | 2002-09-13 | 2008-05-27 | Intercell Ag | Method for isolating hepatitis C virus peptides |
WO2004035618A2 (en) | 2002-10-15 | 2004-04-29 | Intercell Ag | Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
EP2287311A1 (en) | 2003-03-04 | 2011-02-23 | Intercell AG | Streptococcus pyogenes antigens |
AU2004224746B2 (en) | 2003-03-24 | 2009-04-23 | Valneva Austria Gmbh | Improved vaccines |
CA2520868A1 (en) | 2003-03-31 | 2004-10-14 | Intercell Ag | Staphylococcus epidermidis antigens |
EP2311991A1 (en) | 2003-04-15 | 2011-04-20 | Intercell AG | S. pneumoniae antigens |
EP2289907A3 (en) | 2003-05-07 | 2011-08-31 | Intercell AG | Streptococcus agalactiae antigens I + II |
EP2327720A1 (en) | 2003-05-30 | 2011-06-01 | Intercell AG | Enterococcus antigens |
ES2297688T3 (es) | 2004-03-12 | 2008-05-01 | Intercell Ag | Procedimiento para solubizar mezclas de peptidos. |
DE102004038134B4 (de) | 2004-08-05 | 2013-07-25 | Johann Wolfgang Goethe-Universität Frankfurt am Main | Multivalente Chelatoren zum Modifizieren und Organisieren von Zielmolekülen, Verfahren zu ihrer Herstellung sowie ihre Verwendung |
DE602005020815D1 (de) | 2004-09-24 | 2010-06-02 | Intercell Ag | Verändertes vp-1capsidprotein von parvovirus b19 |
CA2583026A1 (en) * | 2004-10-29 | 2006-05-04 | Intercell Ag | Hcv vaccines for chronic hcv patients |
ES2396240T3 (es) * | 2005-04-20 | 2013-02-20 | Mitsuru Akashi | Poliaminoácido para usar como adyuvante |
EP1887084A1 (en) * | 2006-08-10 | 2008-02-13 | International Investment and Patents SA | Plasmids with immunological action |
EP2289906A1 (en) | 2006-09-15 | 2011-03-02 | Intercell AG | Borrelia antigens |
JP2008174490A (ja) * | 2007-01-18 | 2008-07-31 | Nitto Denko Corp | 抗原性ペプチドを主成分とする薬剤 |
AU2008248755A1 (en) | 2007-05-02 | 2008-11-13 | Intercell Ag | Klebsiella antigens |
KR100748265B1 (ko) * | 2007-06-15 | 2007-08-10 | (주)성문엔지니어링 | 공동주택에 배선된 전선의 합선방지구조 |
US20100203075A1 (en) | 2007-06-18 | 2010-08-12 | Intercell Ag | Chlamydia antigens |
CA2695399C (en) | 2007-08-02 | 2017-10-17 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope influenza vaccines |
ES2703571T3 (es) * | 2008-03-27 | 2019-03-11 | Nestec Sa | Métodos para aumentar la absorción de péptidos, peptidomiméticos y otros sustratos de proteína de transporte gastrointestinal |
JP2012510289A (ja) | 2008-12-03 | 2012-05-10 | プロティア ワクチン テクノロジーズ リミテッド | グルタミルtRNA合成酵素(GtS)フラグメント |
EP2405938A2 (en) | 2009-02-13 | 2012-01-18 | Intercell AG | Nontypable haemophilus influenzae antigens |
WO2011024071A1 (en) * | 2009-08-27 | 2011-03-03 | Novartis Ag | Adjuvant comprising aluminium, oligonucleotide and polycation |
EP2498763A4 (en) | 2009-11-09 | 2015-10-07 | Spotlight Technology Partners Llc | HYDROGELS BASED ON POLYSACCHARIDE |
US8795727B2 (en) | 2009-11-09 | 2014-08-05 | Spotlight Technology Partners Llc | Fragmented hydrogels |
WO2011067758A2 (en) | 2009-12-02 | 2011-06-09 | Protea Vaccine Technologies Ltd. | Immunogenic fragments and multimers from streptococcus pneumoniae proteins |
US8765148B2 (en) | 2010-02-19 | 2014-07-01 | Valneva Austria Gmbh | 1C31 nanoparticles |
CN103517713A (zh) | 2011-02-22 | 2014-01-15 | 彼昂德瓦克斯医药有限公司 | 在改善的季节性和大流行性流感疫苗中的多聚体多表位多肽 |
RU2478399C2 (ru) * | 2011-06-16 | 2013-04-10 | Государственное научное учреждение Всероссийский научно-исследовательский институт бруцеллеза и туберкулеза животных Российской академии сельскохозяйственных наук (ГНУ ВНИИБТЖ Россельхозакадемии) | Способ получения специфического иммуномодулятора |
US20140271723A1 (en) * | 2013-03-15 | 2014-09-18 | Saint Louis University | Adjuvant compositions and methods of using thereof |
SG10201912485PA (en) | 2015-05-13 | 2020-02-27 | Agenus Inc | Vaccines for treatment and prevention of cancer |
US20190080044A1 (en) * | 2016-03-15 | 2019-03-14 | Repertoire Genesis Incorporation | Monitoring and diagnosis for immunotherapy, and design for therapeutic agent |
JP2019517577A (ja) * | 2016-05-27 | 2019-06-24 | エトゥビクス コーポレーション | ネオエピトープワクチン組成物及びその使用方法 |
WO2018070069A1 (ja) * | 2016-10-11 | 2018-04-19 | サイトリミック株式会社 | 医薬 |
CN107469067B (zh) * | 2017-09-05 | 2018-06-19 | 浙江大学 | 一种多肽及其改造体在制备免疫调节药物中的应用 |
CN112218883A (zh) | 2018-04-26 | 2021-01-12 | 艾吉纳斯公司 | 热休克蛋白结合肽组合物及其使用方法 |
CN110870912A (zh) * | 2018-08-31 | 2020-03-10 | 成都夸常奥普医疗科技有限公司 | 亚甲蓝类染料作为疫苗佐剂的应用、包含该佐剂的疫苗及其应用 |
CN110870913A (zh) * | 2018-08-31 | 2020-03-10 | 成都夸常奥普医疗科技有限公司 | 氨基酸类营养素作为疫苗佐剂的应用以及包含氨基酸营养素作为佐剂的疫苗 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1290141A (no) | 1968-05-31 | 1972-09-20 | ||
US4847240A (en) * | 1978-01-16 | 1989-07-11 | The Trustees Of Boston University | Method of effecting cellular uptake of molecules |
US4728639A (en) * | 1982-07-27 | 1988-03-01 | University Of Tennessee Research Corporation | Type-specific opsonic antibodies evoked with a synthetic peptide of streptococcal M protein conjugated to polylysine without adjuvant |
US6022544A (en) * | 1983-01-24 | 2000-02-08 | The John Hopkins University | Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
US4956273A (en) * | 1985-10-24 | 1990-09-11 | Southwest Foundation For Biomedical Research | Synthetic peptides and method of use for diagnosis and vaccination for AIDS and ARC |
IL82841A (en) * | 1986-06-13 | 1992-11-15 | Oncogen | Ligands and in vitro methods for augmenting b-cell proliferation |
GB2220939B (en) * | 1988-06-10 | 1992-02-26 | Medical Res Council | Peptide fragments of hiv and their use in vaccines and diagnosis |
EP0440742B1 (en) * | 1988-10-27 | 1997-01-15 | The Regents Of The University Of Minnesota | Liposome immunoadjuvants containing il-2 |
EP0510054A1 (en) | 1990-01-05 | 1992-10-28 | United Biomedical, Inc. | Hiv-1 core protein fragments |
US5342774A (en) | 1991-05-23 | 1994-08-30 | Ludwig Institute For Cancer Research | Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 |
US6235525B1 (en) | 1991-05-23 | 2001-05-22 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof |
DK0636028T3 (da) | 1992-04-03 | 2004-07-12 | Univ California | Selvorganiserende polynucleotidleveringssystem omfattende et amfipatisk kationisk peptid |
ATE280180T1 (de) | 1992-08-31 | 2004-11-15 | Ludwig Inst Cancer Res | Vom mage-3-gen abgeleitetes und von hla-a1 präsentiertes, isoliertes nonapeptid und dessen anwendungen |
US5571711A (en) * | 1993-06-17 | 1996-11-05 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules coding for BAGE tumor rejection antigen precursors |
US5409703A (en) * | 1993-06-24 | 1995-04-25 | Carrington Laboratories, Inc. | Dried hydrogel from hydrophilic-hygroscopic polymer |
CZ5191U1 (cs) * | 1993-07-12 | 1996-09-12 | Aliatros Medical, A.S. | Farmaceutický prostředek pro imunomodulační a adjuvantní léčbu |
JP2828391B2 (ja) * | 1993-10-29 | 1998-11-25 | 東燃株式会社 | オリゴ糖を表面に有するリポソーム |
US6660276B1 (en) * | 1994-02-16 | 2003-12-09 | The University Of Virginia Patent Foundation | Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor |
US6001809A (en) * | 1994-07-11 | 1999-12-14 | Elan Pharmaceuticals, Inc. | Inhibitors of leukocyte adhesion |
UY24367A1 (es) | 1995-11-23 | 2000-10-31 | Boehringer Ingelheim Int | Vacunas contra tumores y procedimiento para su produccion |
CO4600681A1 (es) | 1996-02-24 | 1998-05-08 | Boehringer Ingelheim Pharma | Composicion farmaceutica para la modulacion inmunitaria |
-
1997
- 1997-02-20 CO CO97009092A patent/CO4600681A1/es unknown
- 1997-02-20 RS YUP-62/97A patent/RS50101B/sr unknown
- 1997-02-21 JP JP52980697A patent/JP4184433B2/ja not_active Expired - Fee Related
- 1997-02-21 TR TR1998/01649T patent/TR199801649T2/xx unknown
- 1997-02-21 EE EE9800255A patent/EE04481B1/xx unknown
- 1997-02-21 RO RO98-01305A patent/RO119344B1/ro unknown
- 1997-02-21 PT PT97905068T patent/PT881906E/pt unknown
- 1997-02-21 BR BR9707694A patent/BR9707694A/pt not_active IP Right Cessation
- 1997-02-21 CN CNB971925186A patent/CN1177610C/zh not_active Expired - Fee Related
- 1997-02-21 PL PL97328455A patent/PL189413B1/pl unknown
- 1997-02-21 NZ NZ332020A patent/NZ332020A/en not_active IP Right Cessation
- 1997-02-21 SI SI9730672T patent/SI0881906T2/sl unknown
- 1997-02-21 HU HU9901186A patent/HU224410B1/hu not_active IP Right Cessation
- 1997-02-21 WO PCT/EP1997/000828 patent/WO1997030721A1/de active IP Right Grant
- 1997-02-21 KR KR10-1998-0706339A patent/KR100457647B1/ko not_active IP Right Cessation
- 1997-02-21 AU AU18759/97A patent/AU722264B2/en not_active Ceased
- 1997-02-21 DE DE59711873T patent/DE59711873D1/de not_active Expired - Lifetime
- 1997-02-21 AR ARP970100701A patent/AR005945A1/es active IP Right Grant
- 1997-02-21 EP EP97905068A patent/EP0881906B2/de not_active Expired - Lifetime
- 1997-02-21 SK SK1145-98A patent/SK284582B6/sk not_active IP Right Cessation
- 1997-02-21 ES ES97905068T patent/ES2225951T5/es not_active Expired - Lifetime
- 1997-02-21 MY MYPI97000683A patent/MY119276A/en unknown
- 1997-02-21 AT AT97905068T patent/ATE274350T1/de active
- 1997-02-21 US US09/125,672 patent/US7105162B1/en not_active Expired - Fee Related
- 1997-02-21 CZ CZ19982689A patent/CZ295396B6/cs not_active IP Right Cessation
- 1997-02-21 HR HR970100A patent/HRP970100B1/xx not_active IP Right Cessation
- 1997-02-21 CA CA2243559A patent/CA2243559C/en not_active Expired - Fee Related
- 1997-02-21 IL IL12536197A patent/IL125361A/en not_active IP Right Cessation
- 1997-02-21 DK DK97905068T patent/DK0881906T4/da active
- 1997-02-24 PE PE1997000130A patent/PE55398A1/es not_active IP Right Cessation
- 1997-02-24 ID IDP970541A patent/ID16038A/id unknown
- 1997-02-24 TW TW086102221A patent/TW585774B/zh not_active IP Right Cessation
-
1998
- 1998-08-21 NO NO983850A patent/NO983850L/no not_active Application Discontinuation
- 1998-08-21 BG BG102714A patent/BG63682B1/bg active Active
-
1999
- 1999-05-25 HK HK99102360A patent/HK1017257A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO983850D0 (no) | Farmas°ytisk blanding for immunomodulering basert pÕ peptider og adjuvanser | |
NO992779L (no) | OB-fusjonsproteinpreparater og fremgangsmåte | |
DE69332485D1 (de) | Immunmodulierende peptide | |
IS1810B (is) | Úðablöndur úr peptíðum og próteinum | |
DK1035865T3 (da) | HIV-1-Tat eller derivater deraf til profylaktisk og terapeutisk vaccination | |
IL118059A0 (en) | Recombinant obese proteins | |
DK93992A (da) | Depotpraeparat og fremgangsmaade til fremstilling deraf | |
NO20011801D0 (no) | Adjuvantsystemer og vaksiner | |
DE4393381T1 (de) | Peptide | |
NO974618D0 (no) | Farmasöytiske preparater for intranasal administrasjon | |
DK6893D0 (da) | Peptid | |
NO985680D0 (no) | Peptidderivater | |
NO983849L (no) | Peptidderivater | |
NO990836D0 (no) | Antitrombotiske azacykloalkylalkanoylpeptider og pseudopeptider | |
FI963334A0 (fi) | Tyrosinaasista peräisin olevat eristetyt peptidit ja niiden käyttö | |
NO992091D0 (no) | Farmas°ytiske blandinger inneholdende lamivudin og zidovudin | |
NO980058D0 (no) | Opthalmiske preparater | |
ATA1972000A (de) | Rekombinant hergestelltes menschliches intestinales npt2b-polypeptid | |
DE69427363D1 (de) | Plättchenaggregationsinhibierende peptide | |
GB2331521B (en) | Vaccine preparations | |
DK0456138T3 (da) | Peptidamidaser og anvendelse deraf | |
AU4489896A (en) | Avian recombinant live vaccine | |
MA22717A1 (fr) | Peptides hemoregulateurs | |
NO985572L (no) | Substituerte amidinobenzenderivater og medisinske preparater derav | |
DE69434900D1 (de) | Menschliche chemokin-polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |